This page is historical material reflecting the Feedback Loop Blog as it existed on August 10, 2011. This page is no longer updated and links to external websites and some internal pages may not work.
August 10, 2011

Archived: Planning Grants Now Available for Clinical Trials of High Relevance to the NIGMS Mission

NIGMS supports a limited number of investigator-initiated clinical trials in selected areas related to its mission, including trauma, burn and peri-operative injury; wound healing; sepsis; and anesthesiology and peri-operative pain. We will now offer planning grants (see PAR-11-287) to enable the assembly of the organizational elements and documentation needed for a clinical trial R01 application. This will also permit early peer review of the scientific rationale of a proposed trial. Before applying for a planning grant, we strongly recommend consulting with the appropriate NIGMS program staff listed in the funding opportunity announcement to determine whether the goal of the proposed trial aligns with the NIGMS mission and scientific priorities. Letters of intent for the planning grants are due by September 24, 2011, and applications are due by October 24, 2011. We will accept subsequent submissions on the same dates in 2012 and 2013. As this planning grant program proceeds, we will assess its value to applicants, and we welcome your feedback at any time. For more information, please see the NIGMS Web site on Clinical Studies and Trials.

About the Author

Rochelle M. Long.

Rochelle Long

Rochelle directs the NIGMS division that funds a broad range of research from basic studies in synthetic chemistry, enzymology, biotechnology, chemical biology, and glycosciences to clinical areas that include pharmacology, anesthesia, sepsis, traumatic injury, and wound healing. She is a pharmacologist who has played leading roles in fostering research in pharmacogenomics through national and international collaborations.